Five Prime Therapeutics, Inc. (FPRX) - NASDAQ
From other sites
Company Description
Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on discovering and developing novel protein therapeutics. The company advanced product candidates includes, FPA008, FPA144 and FP-1039/GSK3052230. The FPA008 is an antibody that inhibits colony stimulating... More
Sector: Healthcare
Industry: Biotechnology
Country: United States